2020
DOI: 10.1136/bmjopen-2019-031758
|View full text |Cite
|
Sign up to set email alerts
|

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on aneurysm sac change: protocol of Clarify IMA study

Abstract: IntroductionType II endoleak (EL) is frequently seen after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for aneurysm sac enlargement if it persists. In order to reduce type II EL and consequent sac enlargement, pre-emptive embolisation of the inferior mesenteric artery (IMA), which is a main source for persistent type II EL, has been introduced in many vascular centres. At present, there is a lack of robust evidence to support the efficacy of pre-e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 28 publications
(32 reference statements)
0
5
0
Order By: Relevance
“…Preembolization of IMA or LAs have been performed to prevent ETII. 21,22 Li Q et al reported that pre-embolization of both IMA and LAs significantly reduced the occurrence of ETII. 22 However, not all of ETII lead to aneurysm sac enlargement, and preoperative intervention of both IMA and LAs may be excessive to prevent aneurysm sac enlargement.…”
Section: Discussionmentioning
confidence: 99%
“…Preembolization of IMA or LAs have been performed to prevent ETII. 21,22 Li Q et al reported that pre-embolization of both IMA and LAs significantly reduced the occurrence of ETII. 22 However, not all of ETII lead to aneurysm sac enlargement, and preoperative intervention of both IMA and LAs may be excessive to prevent aneurysm sac enlargement.…”
Section: Discussionmentioning
confidence: 99%
“… 32 An ongoing multicenter randomized trial will try to clarify the efficacy of preoperative IMA embolization. 33 …”
Section: Discussionmentioning
confidence: 99%
“…25,26 Further evidence from multicenter RCTs, such as the Clarify IMA trial, is awaited. 27 As for history of smoking, it significantly prohibited late complications. Since history of smoking has been validated as inhibiting type II endoleak, 21 this probably led to decrease of late complications in our study.…”
Section: Discussionmentioning
confidence: 99%